Reduction in the use of blood components and CMV negative by consultation

被引：0
|
作者：
Rikabi, N [1 ]
Krugh, D [1 ]
Gerwitz, A [1 ]
Kennedy, M [1 ]
机构：
[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA
来源：
TRANSFUSION | 2003年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：164A / 164A
页数：1
相关论文
共 50 条
  • [11] Coagulase-negative staphylococcal contamination of whole blood and its components: the effects of WBC reduction
    Holden, F
    Foley, M
    Devin, G
    Kinsella, A
    Murphy, WG
    TRANSFUSION, 2000, 40 (12) : 1508 - 1513
  • [12] Reduction of O Rh-Negative Blood Use by a Children's Hospital
    Nicol, K.
    Townsend, S.
    Whitman, M.
    Kosanke, J.
    Wissel, M. E.
    TRANSFUSION, 2010, 50 : 266A - 266A
  • [13] The components of consultation
    Taylor, DC
    Moses, KW
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2003, 96 (02) : 83 - 86
  • [14] Study on the Use of CMV seronegative Blood Products in Hospitals
    Lichert, Frank
    TRANSFUSIONSMEDIZIN, 2018, 8 (03) : 147 - 147
  • [15] Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients
    Nash, Tammon
    Hoffmann, Sandra
    Butch, Suzanne
    Davenport, Robertson
    Cooling, Laura
    TRANSFUSION, 2012, 52 (10) : 2270 - 2272
  • [16] Leukocyte reduction in cellular blood components
    Leparc, GF
    LABORATORY MEDICINE, 1997, 28 (05) : 328 - 331
  • [17] OPTIMAL USE OF BLOOD COMPONENTS
    GRAVLEE, GP
    INTERNATIONAL ANESTHESIOLOGY CLINICS, 1990, 28 (04) : 216 - 222
  • [18] CLINICAL USE OF BLOOD, BLOOD COMPONENTS AND BLOOD PRODUCTS
    BLAJCHMAN, MA
    SHEPHERD, FA
    PERRAULT, RA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1979, 121 (01) : 33 - &
  • [19] USE OF THE CYTOMEGALOVIRUS ANTIGENEMIA (CMV-AG) ASSAY FOR THE DETECTION OF CMV IN THE BLOOD OF AIDS PATIENTS
    LIPSON, SM
    KAPLAN, MH
    TSENG, LF
    MANDEL, FS
    CANADIAN JOURNAL OF MICROBIOLOGY, 1993, 39 (11) : 1059 - 1065
  • [20] Persistence of CMV after leukocyte-reduction of blood products.
    Elfath, MD
    Luka, J
    Dumont, LJ
    BLOOD, 1998, 92 (10) : 52A - 52A
12345